Sleep Disorders in Long COVID: Why You Cannot Sleep and What Helps

Sleep disruption is one of the most common and debilitating symptoms of Long COVID, affecting 50–80% of patients in various studies. Unlike ordinary insomnia, Long COVID sleep disorders often involve multiple overlapping mechanisms — dysautonomia, neuroinflammation, mast cell activation, and circadian rhythm disruption — that require targeted approaches rather than standard sleep hygiene advice.

Why Long COVID Disrupts Sleep

Autonomic dysregulation during sleep. In healthy individuals, the autonomic nervous system shifts toward parasympathetic dominance during sleep, allowing heart rate and blood pressure to drop and restorative processes to occur. In Long COVID patients with dysautonomia, this shift is impaired. Heart rate variability studies show that Long COVID patients have persistently elevated sympathetic tone even during sleep, resulting in fragmented sleep architecture, reduced slow-wave sleep, and frequent nocturnal awakenings.

Neuroinflammation and microglial activation. The brainstem and hypothalamus — regions critical for sleep-wake regulation — are directly affected by SARS-CoV-2 neuroinvasion and neuroinflammation. Activated microglia in these regions produce cytokines (IL-1β, TNF-α, IL-6) that disrupt the normal sleep-wake cycle and reduce sleep quality.

Mast cell activation at night. Mast cells have a circadian rhythm, with peak degranulation occurring in the late evening and early morning hours. In Long COVID patients with MCAS, this nocturnal mast cell activity can cause night sweats, flushing, palpitations, and anxiety that disrupt sleep. Many Long COVID patients describe waking between 2–4 AM with adrenaline surges — a pattern consistent with nocturnal mast cell activation.

Histamine and sleep architecture. Histamine is a wakefulness-promoting neurotransmitter. Elevated histamine from mast cell activation or impaired histamine degradation (DAO deficiency, HNMT variants) can cause insomnia and fragmented sleep. This is why some Long COVID patients find that antihistamines (particularly H1 blockers like cetirizine or loratadine taken at night) improve sleep quality.

Circadian rhythm disruption. Long COVID appears to disrupt the circadian clock at a cellular level, possibly through effects on the suprachiasmatic nucleus (the brain's master clock) or through disruption of the gut microbiome (which has its own circadian rhythm). Patients often describe a shifted or fragmented circadian pattern — unable to sleep at night, exhausted during the day, but not able to nap effectively.

Sleep Architecture Changes in Long COVID

Polysomnography studies of Long COVID patients have found:

The reduction in slow-wave sleep is particularly significant because this is the stage where memory consolidation, immune function, and cellular repair occur. Reduced N3 sleep likely contributes to the cognitive dysfunction and immune dysregulation seen in Long COVID.

Evidence-Based Approaches

Low-dose naltrexone (LDN). LDN has been shown to improve sleep quality in ME/CFS and fibromyalgia, conditions with overlapping mechanisms to Long COVID. Its anti-inflammatory effects on microglia may reduce the neuroinflammation disrupting sleep architecture. Several Long COVID specialists report that LDN (1.5–4.5 mg at bedtime) improves sleep quality within 4–8 weeks.

Antihistamines. H1 blockers (cetirizine, loratadine, fexofenadine) and H2 blockers (famotidine) taken in the evening can reduce nocturnal mast cell symptoms and improve sleep onset. The combination of H1 + H2 blockade is commonly used in Long COVID MCAS protocols.

Low-dose quetiapine or mirtazapine. These medications have strong antihistamine properties and are sometimes used off-label in Long COVID for sleep, particularly in patients with comorbid anxiety or MCAS. They should be used cautiously in patients with dysautonomia due to orthostatic hypotension risk.

Melatonin. Melatonin has anti-inflammatory properties beyond its circadian effects and has been studied in Long COVID. Doses of 0.5–5 mg (lower doses are often more effective for circadian entrainment) taken 1–2 hours before target sleep time can help reset the circadian rhythm.

Heart rate-guided sleep positioning. Elevating the head of the bed 30–45 degrees reduces orthostatic stress during sleep and can improve autonomic balance. Many Long COVID POTS patients report significantly better sleep quality with head-of-bed elevation.

Avoiding triggers before bed. For patients with MCAS, avoiding high-histamine foods, alcohol, and NSAIDs in the 3–4 hours before bed can reduce nocturnal mast cell activation. A cool bedroom temperature (65–68°F) also reduces mast cell degranulation.

What Does Not Work (and May Harm)

Standard cognitive behavioral therapy for insomnia (CBT-I) and sleep restriction therapy can worsen Long COVID sleep disorders by increasing sympathetic activation and triggering PEM. Graded exercise therapy for sleep improvement is contraindicated in Long COVID patients with PEM. Benzodiazepines and Z-drugs (zolpidem, eszopiclone) may provide short-term sleep but worsen autonomic function and cognitive symptoms with regular use.

ChatDys resources: Log your sleep quality and nocturnal symptoms in the Health Tracker to identify patterns. If you have MCAS symptoms at night, review our MCAS trigger guide. Upload your genetic data to Genetics to check for HNMT variants affecting histamine metabolism.